Cargando…
Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study
BACKGROUND AND AIMS: Thrombocytopenia occurs frequently in patients with cirrhosis. The immature platelet fraction (IPF%) is measured to differentiate the causes of thrombocytopenia. To date the relevance of thrombopoietin (TPO) in the context of cirrhosis is unknown. The aim of our study was to inv...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810997/ https://www.ncbi.nlm.nih.gov/pubmed/29438423 http://dx.doi.org/10.1371/journal.pone.0192271 |
_version_ | 1783299795111116800 |
---|---|
author | Rauber, Philip Lammert, Frank Grotemeyer, Katharina Appenrodt, Beate |
author_facet | Rauber, Philip Lammert, Frank Grotemeyer, Katharina Appenrodt, Beate |
author_sort | Rauber, Philip |
collection | PubMed |
description | BACKGROUND AND AIMS: Thrombocytopenia occurs frequently in patients with cirrhosis. The immature platelet fraction (IPF%) is measured to differentiate the causes of thrombocytopenia. To date the relevance of thrombopoietin (TPO) in the context of cirrhosis is unknown. The aim of our study was to investigate the cause of thrombocytopenia in patients with liver cirrhosis by measuring IPF%, TPO and spleen size. In addition we examined the use of IPF% to evaluate the severity of cirrhosis and its complications. METHODS: Overall, we included 88 in-patients with cirrhosis in our study. The collected data comprises current health status, blood parameters, severity of cirrhosis evaluated by Child-Pugh score and MELD score, spleen diameter, ascites and esophageal varices. The IPF% was measured using an automatic hematology analyzer. TPO was measured with ELISA. RESULTS: IPF% (p = 0.003) and spleen diameter (p = 0.001) were significantly higher in patients with thrombocytopenia. There was no significant difference in TPO between patients with and without thrombocytopenia. The mean values of IPF% varied significantly (p = 0.044) in Child-Pugh stages. IPF% was significantly (p = 0.005) elevated in patients with esophageal varices. Moreover, IPF% higher than 3.85% displayed sensitivity of 76.6% and specificity of 52.4% with an area under receiver operating curve characteristics of 0.669 for the presence of esophageal varices. CONCLUSION: On closer examination of the three compartments known to have an influence on platelet count splenomegaly seems to be the major cause of thrombocytopenia in patients with cirrhosis according to current knowledge. Higher IPF% in patients with thrombocytopenia indicates peripheral consumption of platelets. The relation between spleen diameter and platelet count indicates the spleen to be the major place of platelets’ consumption. TPO did not differ between patients with and without thrombocytopenia. Furthermore, we cannot exclude an influence of impaired thrombopoietin synthesis on platelet counts. The association between IPF% and platelet count suggests that there is physiological regulation of platelets in patients with cirrhosis. In our study IPF% is associated with esophageal varices and the stage of cirrhosis. Further studies are needed to confirm these results. |
format | Online Article Text |
id | pubmed-5810997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-58109972018-02-28 Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study Rauber, Philip Lammert, Frank Grotemeyer, Katharina Appenrodt, Beate PLoS One Research Article BACKGROUND AND AIMS: Thrombocytopenia occurs frequently in patients with cirrhosis. The immature platelet fraction (IPF%) is measured to differentiate the causes of thrombocytopenia. To date the relevance of thrombopoietin (TPO) in the context of cirrhosis is unknown. The aim of our study was to investigate the cause of thrombocytopenia in patients with liver cirrhosis by measuring IPF%, TPO and spleen size. In addition we examined the use of IPF% to evaluate the severity of cirrhosis and its complications. METHODS: Overall, we included 88 in-patients with cirrhosis in our study. The collected data comprises current health status, blood parameters, severity of cirrhosis evaluated by Child-Pugh score and MELD score, spleen diameter, ascites and esophageal varices. The IPF% was measured using an automatic hematology analyzer. TPO was measured with ELISA. RESULTS: IPF% (p = 0.003) and spleen diameter (p = 0.001) were significantly higher in patients with thrombocytopenia. There was no significant difference in TPO between patients with and without thrombocytopenia. The mean values of IPF% varied significantly (p = 0.044) in Child-Pugh stages. IPF% was significantly (p = 0.005) elevated in patients with esophageal varices. Moreover, IPF% higher than 3.85% displayed sensitivity of 76.6% and specificity of 52.4% with an area under receiver operating curve characteristics of 0.669 for the presence of esophageal varices. CONCLUSION: On closer examination of the three compartments known to have an influence on platelet count splenomegaly seems to be the major cause of thrombocytopenia in patients with cirrhosis according to current knowledge. Higher IPF% in patients with thrombocytopenia indicates peripheral consumption of platelets. The relation between spleen diameter and platelet count indicates the spleen to be the major place of platelets’ consumption. TPO did not differ between patients with and without thrombocytopenia. Furthermore, we cannot exclude an influence of impaired thrombopoietin synthesis on platelet counts. The association between IPF% and platelet count suggests that there is physiological regulation of platelets in patients with cirrhosis. In our study IPF% is associated with esophageal varices and the stage of cirrhosis. Further studies are needed to confirm these results. Public Library of Science 2018-02-13 /pmc/articles/PMC5810997/ /pubmed/29438423 http://dx.doi.org/10.1371/journal.pone.0192271 Text en © 2018 Rauber et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Rauber, Philip Lammert, Frank Grotemeyer, Katharina Appenrodt, Beate Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study |
title | Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study |
title_full | Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study |
title_fullStr | Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study |
title_full_unstemmed | Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study |
title_short | Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study |
title_sort | immature platelet fraction and thrombopoietin in patients with liver cirrhosis: a cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810997/ https://www.ncbi.nlm.nih.gov/pubmed/29438423 http://dx.doi.org/10.1371/journal.pone.0192271 |
work_keys_str_mv | AT rauberphilip immatureplateletfractionandthrombopoietininpatientswithlivercirrhosisacohortstudy AT lammertfrank immatureplateletfractionandthrombopoietininpatientswithlivercirrhosisacohortstudy AT grotemeyerkatharina immatureplateletfractionandthrombopoietininpatientswithlivercirrhosisacohortstudy AT appenrodtbeate immatureplateletfractionandthrombopoietininpatientswithlivercirrhosisacohortstudy |